The role of N-acetylcysteine in the management of COPD: A review of recent literature
(Bentham Science Publishers) Recent studies indicate the clinical significant effects of N-Acetylcysteine such as reducing exacerbation frequency are seen at daily doses 1,200 mg or greater.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Acetylcysteine | Chronic Obstructive Pulmonary | Health | International Medicine & Public Health | Science | Study